204 related articles for article (PubMed ID: 22222194)
1. Which patients pursue fertility preservation treatments? A multicenter analysis of the predictors of fertility preservation in women with breast cancer.
Kim J; Oktay K; Gracia C; Lee S; Morse C; Mersereau JE
Fertil Steril; 2012 Mar; 97(3):671-6. PubMed ID: 22222194
[TBL] [Abstract][Full Text] [Related]
2. Risks associated with fertility preservation for women with sickle cell anemia.
Pecker LH; Maher JY; Law JY; Beach MC; Lanzkron S; Christianson MS
Fertil Steril; 2018 Sep; 110(4):720-731. PubMed ID: 30196969
[TBL] [Abstract][Full Text] [Related]
3. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for fertility preservation in pediatric and adolescent girls with planned gonadotoxic treatment.
Mgboji GE; Cordeiro Mitchell CN; Bedrick BS; Vaidya D; Tao X; Liu Y; Maher JY; Christianson MS
J Assist Reprod Genet; 2021 Oct; 38(10):2713-2721. PubMed ID: 34370210
[TBL] [Abstract][Full Text] [Related]
5. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies.
Meirow D; Raanani H; Maman E; Paluch-Shimon S; Shapira M; Cohen Y; Kuchuk I; Hourvitz A; Levron J; Mozer-Mendel M; Brengauz M; Biderman H; Manela D; Catane R; Dor J; Orvieto R; Kaufman B
Fertil Steril; 2014 Aug; 102(2):488-495.e3. PubMed ID: 24934489
[TBL] [Abstract][Full Text] [Related]
7. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in cancer patients who did or did not pursue fertility preservation.
Moravek MB; Confino R; Smith KN; Kazer RR; Klock SC; Lawson AK; Gradishar WJ; Pavone ME
Fertil Steril; 2018 Feb; 109(2):349-355. PubMed ID: 29338854
[TBL] [Abstract][Full Text] [Related]
9. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
10. Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?
Crown A; Muhsen S; Zabor EC; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2020 Nov; 27(12):4740-4749. PubMed ID: 32767225
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation does not delay the initiation of chemotherapy in breast cancer patients treated with adjuvant or neo-adjuvant chemotherapy.
D'Hondt C; Vanhoeij M; Van Moer E; Segers I; Fontaine C; Tournaye H; De Vos M
Breast Cancer Res Treat; 2020 Nov; 184(2):433-444. PubMed ID: 32794060
[TBL] [Abstract][Full Text] [Related]
12. Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients.
Karatas F; Erdem GU; Sahin S; Aytekin A; Yuce D; Sever AR; Babacan T; Ates O; Ozisik Y; Altundag K
Breast; 2017 Apr; 32():237-244. PubMed ID: 27318645
[TBL] [Abstract][Full Text] [Related]
13. Fertility preservation in women with breast cancer undergoing adjuvant chemotherapy: a systematic review.
Cruz MR; Prestes JC; Gimenes DL; Fanelli MF
Fertil Steril; 2010 Jun; 94(1):138-43. PubMed ID: 19339000
[TBL] [Abstract][Full Text] [Related]
14. Patterns of Fertility Preservation and Pregnancy Outcome After Breast Cancer at a Large Comprehensive Cancer Center.
Dieci MV; Ghiotto C; Barbieri C; Griguolo G; Saccardi C; Gangemi M; Pluchinotta A; Di Liso E; Giorgi CA; Giarratano T; Tasca G; Vernaci G; Faggioni G; Conte P; Guarneri V
J Womens Health (Larchmt); 2019 Apr; 28(4):544-550. PubMed ID: 29963941
[TBL] [Abstract][Full Text] [Related]
15. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
Mougalian SS; Soulos PR; Killelea BK; Lannin DR; Abu-Khalaf MM; DiGiovanna MP; Sanft TB; Pusztai L; Gross CP; Chagpar AB
Cancer; 2015 Aug; 121(15):2544-52. PubMed ID: 25902916
[TBL] [Abstract][Full Text] [Related]
16. Effects of neoadjuvant chemotherapy on operative adverse events and chemotherapy and radiotherapy in patients undergoing immediate breast reconstruction.
Adachi Y; Okumura S; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Sugino K; Horisawa N; Ozaki Y; Endo Y; Sakamoto S; Iwata H
Breast Cancer; 2020 Jul; 27(4):716-723. PubMed ID: 32162180
[TBL] [Abstract][Full Text] [Related]
17. Determinants of access to fertility preservation in women with breast cancer.
Lee S; Heytens E; Moy F; Ozkavukcu S; Oktay K
Fertil Steril; 2011 May; 95(6):1932-6. PubMed ID: 21371704
[TBL] [Abstract][Full Text] [Related]
18. The Shifting Paradigm for Breast Cancer Surgery in Patients Undergoing Neoadjuvant Chemotherapy.
Kantor O; Ajmani G; Wang CH; Datta A; Yao K
Ann Surg Oncol; 2018 Jan; 25(1):164-172. PubMed ID: 29127538
[TBL] [Abstract][Full Text] [Related]
19. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
20. Variation in use of neoadjuvant chemotherapy in patients with stage III breast cancer: Results of the Dutch national breast cancer audit.
Spronk PER; van Bommel ACM; Siesling S; Wouters MWJM; Vrancken Peeters MTFD; Smorenburg CH
Breast; 2017 Dec; 36():34-38. PubMed ID: 28942098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
